We assessed the clinical specificity and prognostic value of WT1 expression in children with BCP-ALL in a comparatively large clinical data set and found a clear subgroup heterogeneity in the prognostic significance of WT1 gene. This evidence concerns the gene WT1 and acute lymphoblastic leukemia.